CME Group price target raised to $263 from $256 at Morgan Stanley

Morgan Stanley raised the firm’s price target on CME Group (CME) to $263 from $256 and keeps an Equal Weight rating on the shares. In a model refresh following Q4 results, the firm is raising its 2025 adjusted EPS view by 3.6% to $10.97 from $10.59.